Fox Business
Expand
Browse All Video
Watch Live

You're watching...

Fake Cancer Drug Found in U.S.

Details

  • Description

    FBN's Dennis Kneale on counterfeit Avastin distributed in the U.S.

  • Duration 2:57
  • Date

Clips

Also in this playlist...

Latest Video

Auto-advance: ON

Auto-advance
View All

Transcript

This transcript is automatically generated

-- -- Fox Business alert users of Avastin on edge after Roche the maker of the best selling cancer drug warm patients hospitals and doctors.

About counterfeit versions appearing in the US market Dennis mills been investigating historic does how widespread.

Is this frankly shocking news -- -- -- cancer -- It will it is so rare that that's why qualified as page one coverage in the Wall Street Journal today.

Taken this extraordinary step -- where it -- yet actual counterfeit drug really making it into the legitimate.

US drug -- -- this isn't the case of up.

An actual generic version of Viagra made in that simple black market lab in China or or in India this is worse this is.

Something some blood sugar -- -- some innocuous substance masquerading as his cancer treatment.

That that can -- I had months to the lives of cancer patients and so these are counterfeiters in going after a vast and have gone after a very high profile drug you know it's -- numbers -- by Genentech which got acquired by Roche.

You would have billions of dollars a year in sales fox brings us two point seven -- have been better after that.

Plus if it's a fascinating drug because what it does is it targets tumors ability to grow blood vessel so that you keep expanding and it -- it.

There are no quite direct rivals are for five of the drugs like it but they're not anywhere near -- biggest sellers apparently.

There's a drug from regeneron and of -- -- that all of -- in trials right now -- go right up against that.

So there's no other stock -- -- struggle benefit but this a big problem because it's a scary thing.

Because now you have to worry about.

All drugs because we're -- sort of -- this -- -- problems before with like ally which is the weight loss drug exposed attack over the -- a very public GlaxoSmithKline that's.

-- -- -- -- -- Now also from Roche to we're talking yeah yeah this is a much more and noticed that hospitals doctors -- a lot of these took down and an -- care so so instead it's a matter of months of life so how do you even know that -- not on the right drug how would you pick up a simple fix for this is not -- but you -- RFID chip technology every -- ball since 2007 they've been testing and on some drugs.

And in May there's a big industry conference where this could now take on extra added -- intensity because of this.

Intensity with Roche overseas Genentech and -- -- -- the company another stock is only down nine cents for showing the AG artists and this is a European company but not a lot of pressure on the stock I mean is it consent -- -- traders felt confident that they can.

-- what says -- as it was only a small.

Isolated cases main issues medical centers mostly in California they have no idea whether any patient actually took the drug.

And they have no idea whether they side effects so so far the damage is very limited all it's just that fear factor that ends up kind of rippling through well with -- more manufacturing happening overseas that is a very.

New fair concern about -- on drug made.

I guess though that these are RFID chips look for -- look for some play there yeah in terms of of a new usage for the entire industry Dennis great story not great but that fastening anyway thank you very much Dennis --

Load More